https://www.selleckchem.com/pr....oducts/disodium-Crom
es mellitus. Direct acting antiviral agents (DAAs) have greatly improved the clearance of hepatitis C virus (HCV) infection. The effect of DAAs on renal function in post-liver transplant HCV-positive patients remains questionable, especially considering the possibility of drug interactions between immunosuppressants and DAAs. A retrospective observational study included 84 post-liver transplant patients with HCV infection. Patients were divided into two groups group I received sofosbuvir plus ribavirin for 24 weeks, group